Latest Articles

Publication Date
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer The ASCO Post

Published: Jan. 12, 2026, 6:10 p.m.
En Bloc Hysterectomy with segmental bowel resection by NOSE-procedure: Surgical Management of Ovarian Cancer in context of Deep Infiltrating Endometriosis.

To show the safety of en bloc hysterectomy with segmental bowel resection utilizing the NOSE-technique in the management of ovarian cancer and deep infiltrating endometriosis (DIE).

Published: Jan. 12, 2026, midnight
‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment - SurvivorNet

‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment SurvivorNet

Published: Jan. 11, 2026, 6:06 p.m.
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology

Published: Jan. 11, 2026, 4:14 p.m.
Development and validation of a nomogram model for predicting natural pregnancy after hysteroscopy and laparoscopy in patients with tubal infertility complicated with pelvic endometriosis.

This study aimed to construct and validate a nomogram for predicting natural pregnancy after hysteroscopy and laparoscopy in patients with tubal infertility and pelvic endometriosis, providing a basis for precise …

Published: Jan. 11, 2026, midnight
‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now - SurvivorNet

‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now SurvivorNet

Published: Jan. 10, 2026, 5:07 p.m.
Acrivon Therapeutics Spotlights ACR368 Endometrial Cancer Data, Adds Serous Arm 3 and FDA Phase 3 Plan - Defense World

Acrivon Therapeutics Spotlights ACR368 Endometrial Cancer Data, Adds Serous Arm 3 and FDA Phase 3 Plan Defense World

Published: Jan. 10, 2026, 6:12 a.m.
Significance of Follicle-Stimulating Hormone Receptor Gene Single-Nucleotide Polymorphism rs6165/rs6166 Analysis for Infertility-Associated Ovarian Disease Susceptibility Prediction and Optimized Individualized Ovulation Induction/Ovarian Stimulation.

Follicle-stimulating hormone receptor (FSHR) is expressed on the plasma membrane of granulosa cells in the ovarian follicles. FSHR is involved in the development and maturation of Graafian follicles, along with …

Published: Jan. 10, 2026, midnight
Endometrial Cancer: Evaluating Platinum Re-Challenge Strategies Through the ECHO-EU Lens - OncLive

Endometrial Cancer: Evaluating Platinum Re-Challenge Strategies Through the ECHO-EU Lens OncLive

Published: Jan. 9, 2026, 8:25 p.m.
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data - Investing.com UK

Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data Investing.com UK

Published: Jan. 9, 2026, 2:25 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!